80 FR 38465 - Manufacturer of Controlled Substances Registration: Johnson Matthey, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 80, Issue 128 (July 6, 2015)
Drug Enforcement Administration
Federal Register Volume 80, Issue 128 (July 6, 2015)
| Page Range | 38465-38465 | |
| FR Document | 2015-16452 |
[Federal Register Volume 80, Number 128 (Monday, July 6, 2015)] [Notices] [Page 38465] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-16452] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Manufacturer of Controlled Substances Registration: Johnson Matthey, Inc. ACTION: Notice of registration. ----------------------------------------------------------------------- SUMMARY: Johnson Matthey, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated February 11, 2015, and published in the Federal Register on February 19, 2015, 80 FR 8901, Johnson Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066-1742 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed: ------------------------------------------------------------------------ Controlled substance Schedule ------------------------------------------------------------------------ Gamma Hydroxybutyric Acid (2010)........... I Marihuana (7360)........................... I Tetrahydrocannabinols (7370)............... I Dihydromorphine (9145)..................... I Difenoxin (9168)........................... I Propiram (9649)............................ I Amphetamine (1100)......................... II Methamphetamine (1105)..................... II Lisdexamfetamine (1205).................... II Methylphenidate (1724)..................... II Nabilone (7379)............................ II Cocaine (9041)............................. II Codeine (9050)............................. II Dihydrocodeine (9120)...................... II Oxycodone (9143)........................... II Hydromorphone (9150)....................... II Diphenoxylate (9170)....................... II Ecgonine (9180)............................ II Hydrocodone (9193)......................... II Meperidine (9230).......................... II Methadone (9250)........................... II Methadone intermediate (9254).............. II Morphine (9300)............................ II Thebaine (9333)............................ II Oxymorphone (9652)......................... II Noroxymorphone (9668)...................... II Alfentanil (9737).......................... II Remifentanil (9739)........................ II Sufentanil (9740).......................... II Tapentadol (9780).......................... II Fentanyl (9801)............................ II ------------------------------------------------------------------------ The company plans to manufacture the listed controlled substances in bulk for sale to its customers. Dated: June 25, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2015-16452 Filed 7-2-15; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 80, No. 128 / Monday, July 6, 2015 / Notices 38465
the Commission determined that it Commission’s Web site at http:// the public interest and with United
would conduct expedited reviews edis.usitc.gov. States obligations under international
pursuant to section 751(c)(3) of the In accordance with sections 201.16(c) treaties, conventions, or protocols in
Tariff Act of 1930 (19 U.S.C. 1675(c)(3)). and 207.3 of the rules, each document effect on May 1, 1971. The DEA
For further information concerning filed by a party to the reviews must be investigated the company’s maintenance
the conduct of these reviews and rules served on all other parties to the reviews of effective controls against diversion by
(as identified by either the public or BPI inspecting and testing the company’s
of general application, consult the
service list), and a certificate of service physical security systems, verifying the
Commission’s Rules of Practice and
must be timely filed. The Secretary will company’s compliance with state and
Procedure, part 201, subparts A and B
not accept a document for filing without local laws, and reviewing the company’s
(19 CFR part 201), and part 207,
a certificate of service.
subparts A, D, E, and F (19 CFR part Determination. The Commission has background and history.
207). determined these reviews are Therefore, pursuant to 21 U.S.C.
Staff report. A staff report containing extraordinarily complicated and 823(a), and in accordance with 21 CFR
information concerning the subject therefore has determined to exercise its 1301.33, the above-named company is
matter of these reviews was placed in authority to extend the review period by granted registration as a bulk
the nonpublic record on June 19, 2015, up to 90 days pursuant to 19 U.S.C. manufacturer of the basic classes of
and made available to persons on the 1675(c)(5)(B). controlled substances listed:
Administrative Protective Order service Authority: These reviews are being
list for these reviews. A public version conducted under authority of title VII of the Controlled substance Schedule
will be issued thereafter, pursuant to Tariff Act of 1930; this notice is published
section 207.62(d)(4) of the pursuant to section 207.62 of the Gamma Hydroxybutyric Acid I
Commission’s rules. Commission’s rules. (2010).
Marihuana (7360) ......................... I
Written submissions. As provided in By order of the Commission.
Tetrahydrocannabinols (7370) ..... I
section 207.62(d) of the Commission’s Issued: June 29, 2015. Dihydromorphine (9145) ............... I
rules, interested parties that are parties William R. Bishop, Difenoxin (9168) ........................... I
to these reviews and that have provided Supervisory Hearings and Information Propiram (9649) ........................... I
individually adequate responses to the Officer. Amphetamine (1100) .................... II
notice of institution,2 and any party [FR Doc. 2015–16434 Filed 7–2–15; 8:45 am] Methamphetamine (1105) ............ II
other than an interested party to these BILLING CODE 7020–02–P Lisdexamfetamine (1205) ............. II
reviews may file written comments with Methylphenidate (1724) ................ II
the Secretary on what determination the Nabilone (7379) ............................ II
Commission should reach in these DEPARTMENT OF JUSTICE Cocaine (9041) ............................. II
reviews. Comments are due on or before Codeine (9050) ............................. II
July 6, 2015 and may not contain new Drug Enforcement Administration Dihydrocodeine (9120) ................. II
factual information. Any person that is Oxycodone (9143) ........................ II
[Docket No. DEA–392]
neither a party to these five-year reviews Hydromorphone (9150) ................ II
nor an interested party may submit a Manufacturer of Controlled Diphenoxylate (9170) ................... II
brief written statement (which shall not Substances Registration: Johnson Ecgonine (9180) ........................... II
contain any new factual information) Matthey, Inc. Hydrocodone (9193) ..................... II
pertinent to the reviews by July 6, 2015. Meperidine (9230) ........................ II
However, should the Department of ACTION: Notice of registration. Methadone (9250) ........................ II
Commerce extend the time limit for its Methadone intermediate (9254) ... II
completion of the final results of its SUMMARY: Johnson Matthey, Inc. applied Morphine (9300) ........................... II
reviews, the deadline for comments to be registered as a manufacturer of Thebaine (9333) ........................... II
(which may not contain new factual certain basic classes of controlled Oxymorphone (9652) ................... II
information) on Commerce’s final substances. The Drug Enforcement Noroxymorphone (9668) .............. II
results is three business days after the Administration (DEA) grants Johnson Alfentanil (9737) ........................... II
Matthey, Inc. registration as a Remifentanil (9739) ...................... II
issuance of Commerce’s results. If
manufacturer of those controlled Sufentanil (9740) .......................... II
comments contain business proprietary
substances. Tapentadol (9780) ........................ II
information (BPI), they must conform
with the requirements of sections 201.6, SUPPLEMENTARY INFORMATION: By notice Fentanyl (9801) ............................ II
207.3, and 207.7 of the Commission’s dated February 11, 2015, and published
rules. Please be aware that the in the Federal Register on February 19, The company plans to manufacture
Commission’s rules with respect to 2015, 80 FR 8901, Johnson Matthey, the listed controlled substances in bulk
filing have changed. The most recent Inc., Custom Pharmaceuticals for sale to its customers.
amendments took effect on July 25, Department, 2003 Nolte Drive, West
Dated: June 25, 2015.
2014. See 79 FR 35920 (June 25, 2014), Deptford, New Jersey 08066–1742
applied to be registered as a Joseph T. Rannazzisi,
and the revised Commission Handbook
on E-filing, available from the manufacturer of certain basic classes of Deputy Assistant Administrator.
controlled substances. No comments or [FR Doc. 2015–16452 Filed 7–2–15; 8:45 am]
Lhorne on DSK7TPTVN1PROD with NOTICES
available from the Office of the Secretary and at the objections were submitted for this BILLING CODE 4410–09–P
Commission’s Web site. notice.
2 The Commission has found the responses The DEA has considered the factors in
submitted by L.K. Bowman Co., Monterey 21 U.S.C. 823(a) and determined that
Mushrooms, Inc., and The Mushroom Co. to be
individually adequate. Comments from other
the registration of Johnson Matthey, Inc.
interested parties will not be accepted (see 19 CFR to manufacture the basic classes of
207.62(d)(2)). controlled substances is consistent with
VerDate Sep<11>2014 14:37 Jul 02, 2015 Jkt 235001 PO 00000 Frm 00039 Fmt 4703 Sfmt 9990 E:\FR\FM\06JYN1.SGM 06JYN1](https://thefederalregister.org/doc/80_FR_38593/page/1.svg)
Document Created: 2015-12-15 13:17:11
Document Modified: 2015-12-15 13:17:11
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of registration. | |
| FR Citation | 80 FR 38465 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR